Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer

Centre Oscar Lambret25 enrolled

Overview

25 patients, treated by brachytherapy in a phase II study "Mammosite" (from 2003 to 2005), will be asked to attend a clinical exam in order to evaluate the late cutaneous toxicity due to brachytherapy. During this consultation, a blood sample will be taken for analysis ( rate of CD8 T-Lymphocyte Apoptosis)

This is an interventional study for the french law

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Breast Cancer

Interventions

Blood sampleBIOLOGICAL

Blood sample taken for the analysis of the rate of CD8 T-Lymphocyte Apoptosis

Clinical examPROCEDURE

Assessment of the esthetic score, and the late cutaneous side effect by 2 physicians

Eligibility

Sex: FEMALEMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patient treated by exclusive per-operative brachytherapy in the prior study Mammosite for breast cancer * Patient with social security Exclusion Criteria: * Not applicable

Locations (1)

Centre Oscar Lambret

Lille, France

Outcomes

Primary Outcomes

Assessment of the rate of Radiation-Induced CD8 T-Lymphocyte Apoptosis

Time frame: Blood sample during a consultation